The Lung Group offers its members access to information regarding current and emerging therapeutic strategies for the treatment of lung cancer and malignant pleural mesothelioma, as well as discussion of new diagnostics and basic research.

The Group has strong links with The Thoracic Society of Australia & New Zealand and the Australasian Lung Cancer Trials Group, and aims to play a pivotal role in advancing knowledge of the most common fatal malignancy in Australian society.

Chair: Dr Nick Pavlakis